Who
Michel Lagarde
President and CEO
Company insider
Files Form 4 as: President and CEO, West Pharmaceutical Services; Director, Vertex Pharmaceuticals; Executive Vice President, Thermo Fisher Scientific; President, Patheon; Director and 10% owner, Patheon.
In numbers
- Trades disclosed
- 209
- Buys
- 5
- Sells
- 15
- Bought
- $1.5M
- Sold
- $132.4M
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 31 Jan 2012
- Last trade
- 8 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Sep 2026filed 10 Sep 2026 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | —13,879 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | —11,081 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | —12,088 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | —13,879 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | —11,081 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | —12,088 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | —6,200 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,950 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,600 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | —6,200 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,950 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,600 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,866 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | VRTX Vertex Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,866 at $0.00 | filing |
| 28 Feb 2026filed 2 Mar 2026 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code F | $436K836.88 at $521.11 | filing |
| 28 Feb 2026filed 2 Mar 2026 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code F | $187K359.725 at $521.11 | filing |
| 28 Feb 2026filed 2 Mar 2026 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code F | $436K836.88 at $521.11 | filing |
| 28 Feb 2026filed 2 Mar 2026 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code F | $187K359.73 at $521.11 | filing |
| 25 Feb 2026filed 27 Feb 2026 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code A | —2,231 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | TMO Thermo Fisher ScientificLife-science tools | SEC FORM 4 Code A | —2,231 at $0.00 | filing |
News
Thermo Fisher Scientific Outperforms on Strong Results and Life Sciences RecoveryTMO · insidermonkey.com · 16 Oct 2026Thermo Fisher Scientific Inc. $TMO Shares Acquired by Artemis Investment Management LLPTMO · dailypolitical.com · 8 Oct 2026Thermo Fisher Scientific (TMO) Drops 4% After Hours to $657TMO · 247wallst.com · 6 Oct 2026
0 headlines in the last 90 days name Michel Lagarde; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.